PCN145 COST EFFECTIVENESS OF FRUQUINTINIB VERSUS...

Value in Health 2019 / 05 Vol. 22

PCN145 COST EFFECTIVENESS OF FRUQUINTINIB VERSUS REGORAFENIB AS THE THIRD-LINE THERAPY FOR PATIENTS WITH METASTATIC COLORECTAL CANCER IN CHINA

Xin, G., Li, H.C., Peng, C., Wang, N., Ma, X., Xiong, X.M., Ma, A.X.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.269
Date:
May, 2019
File:
PDF, 324 KB
english, 2019
Conversion to is in progress
Conversion to is failed